HRAS and non-small cell lung carcinoma: Furthermore, the ROC analyses revealed that the assessment of YY1 levels might be predictive for a certain NSCLC molecular subtype, as high YY1 expression was correlated with a more aggressive phenotype characterized by the higher expressions of MYCN, PI3K and HRAS signature oncogenes.